Evolution of the Average Target: Amarin Corporation plc

Evolution of the Average Target - Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Evolution of the Target Price - Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

08e.wqoRWx2N2CUhPuLexbH9ocvzp00DsRYG3yDc-UZ3WyU.8YdQYlPOsUFpddaXlcez-4zF7TpH-XpIk0O3gT8aAnOonX8OS-OXVWZKuw~8c0357c2f7b7791dcc6790e483a09640
27/10/25 Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit RE
25/06/25 RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal MT
25/10/23 Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3 MT
19/07/23 Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating MT
06/01/23 Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30 MT
19/10/22 SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating MT
06/05/22 JPMorgan Downgrades Amarin to Underweight From Neutral MT
05/05/22 HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10 MT
05/05/22 SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10 MT
05/05/22 Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9 MT
16/02/22 SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating MT
31/01/22 SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating MT
12/05/21 Amarin : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6 MT
01/02/21 Amarin : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating MT
23/12/20 Amarin : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating MT
07/12/20 Amarin : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +3.91%
+20.88%
+39.25%
+20.5%
+13.53%
+36.56%
+22.87%
+49.08%
+10.4%
+19.76%
Average +23.67%
Weighted average by Cap. +25.81%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
12.03USD
Average target price
12.50USD
Spread / Average Target
+3.91%
High Price Target
13.00USD
Spread / Highest target
+8.06%
Low Price Target
12.00USD
Spread / Lowest Target
-0.25%

Analyst Consensus Detail

Analyst consensus - Amarin Corporation plc

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Amarin Corporation plc
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - Amarin Corporation plc
  1. Stock Market
  2. Stocks
  3. AMRN Stock
  4. Consensus Amarin Corporation plc